CSRxP: Senate Finance Takes Positive Steps to Hold Big Pharma Accountable, Lower Drug Prices
Commends Bipartisan Collaboration on Several Market-Based Solutions… Read More
Commends Bipartisan Collaboration on Several Market-Based Solutions… Read More
Looks Forward to Working With Senate Finance Members to Hold Big Pharma… Read More
Drug Makers’ Shares Hit ‘All-Time High’ Off Of Price-Gouging American… Read More
Drug Maker Bests Q2 Forecasts After Hiking Prices on Dozens of Drugs in 2019… Read More
Greater List Price Transparency Will Help Hold Big Pharma Accountable… Read More
Drug Makers Continue Price-Gouging Patients as Americans Demand Accountability… Read More
Decision to Sideline Misguided Proposal a Huge Win for America’s Seniors… Read More
Proposed Bill Would Undermine Fair and Efficient Review Process Washington,… Read More
Senators Advance Three Measures to Help Lower Drug Prices as Momentum to Hold… Read More
Advancement of CREATES and FAIR Drug Pricing Acts Marks Step Toward Boosting… Read More
This week, Big Pharma giant AbbVie announced plans to acquire drug maker… Read More
Encourages Senate Panel to Further Strengthen Drug Price Package with REMEDY… Read More